Partnerships & Mergers

The partnership will begin with a study focused on assessing Mirai’s ability to predict breast cancer risk specifically in Japanese women using mammography images.

The two pharmaceutical giants originally signed the agreement in October 2025, establishing a framework centered on bispecific antibodies and ADCs.

The clinic addresses a critical need revealed by hospital data showing that 20% of burn cases directly result from violence against women.

Regeneron is investing USD 150 million in equity and upfront payments to acquire half of the global development and commercialization rights for TSRA-196.

The partnership combines Philips’ next-generation MR technology with Cortechs.ai’s AI-driven quantitative neuroimaging software to transform how doctors detect, monitor, and manage neurological diseases.

The agreement encompasses the manufacturing and supply of several Algorithm products licensed in the European Union and Japan.

This collaboration establishes a comprehensive framework designed to strengthen pediatric services throughout Dubai Health’s extensive network of medical facilities.

The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.

The procedure demonstrates how deeply Omani and Kuwaiti medical expertise can integrate when supported by cutting-edge technology.

The deal promises to generate up to USD90 million in savings for Gavi and participating countries over the next five years.